Brandes Investment Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68.4M Sell
279,660
-139,502
-33% -$32.5M 0.48% 74
2025
Q4
$86.7M Sell
419,162
-1,888
-0.4% -$373K 0.66% 56
2025
Q3
$78.1M Buy
421,050
+10,285
+3% +$1.76M 0.63% 59
2025
Q2
$62.7M Buy
410,765
+8,502
+2% +$1.31M 0.57% 58
2025
Q1
$66.7M Buy
402,263
+5,331
+1% +$834K 0.68% 53
2024
Q4
$57.4M Buy
396,932
+55,609
+16% +$8.62M 0.64% 56
2024
Q3
$55.3M Buy
341,323
+16,757
+5% +$2.67M 0.62% 55
2024
Q2
$47.4M Buy
324,566
+47,292
+17% +$7.03M 0.58% 60
2024
Q1
$43.9M Buy
277,274
+8,755
+3% +$1.39M 0.56% 59
2023
Q4
$42.1M Buy
268,519
+54,639
+26% +$8.38M 0.64% 54
2023
Q3
$33.3M Buy
213,880
+42,337
+25% +$6.99M 0.65% 50
2023
Q2
$28.4M Buy
171,543
+8,391
+5% +$1.35M 0.57% 53
2023
Q1
$25.3M Buy
163,152
+33,162
+26% +$5.35M 0.54% 57
2022
Q4
$23M Sell
129,990
-22,663
-15% -$3.91M 0.64% 51
2022
Q3
$24.9M Buy
152,653
+6,817
+5% +$1.15M 0.65% 43
2022
Q2
$25.9M Buy
145,836
+12,101
+9% +$2.16M 0.63% 48
2022
Q1
$23.7M Buy
133,735
+14,948
+13% +$2.54M 0.51% 49
2021
Q4
$20.3M Buy
118,787
+1,327
+1% +$217K 0.44% 63
2021
Q3
$19M Buy
117,460
+11,180
+11% +$1.91M 0.41% 67
2021
Q2
$17.5M Buy
106,280
+38,444
+57% +$6.36M 0.39% 67
2021
Q1
$11.2M Buy
67,836
+6,729
+11% +$1.09M 0.26% 78
2020
Q4
$9.54M Buy
61,107
+6,591
+12% +$973K 0.25% 81
2020
Q3
$8.12M Sell
54,516
-12,340
-18% -$1.83M 0.28% 78
2020
Q2
$9.4M Sell
66,856
-9,871
-13% -$1.44M 0.29% 76
2020
Q1
$10.1M Buy
76,727
+24,732
+48% +$3.51M 0.35% 70
2019
Q4
$7.58M Sell
51,995
-928
-2% -$126K 0.18% 80
2019
Q3
$6.85M Sell
52,923
-2,244
-4% -$296K 0.18% 81
2019
Q2
$7.68M Sell
55,167
-2,405
-4% -$333K 0.17% 80
2019
Q1
$8.05M Buy
57,572
+3,052
+6% +$409K 0.19% 78
2018
Q4
$7.04M Buy
54,520
+1,691
+3% +$236K 0.18% 82
2018
Q3
$7.3M Sell
52,829
-1,818
-3% -$242K 0.16% 82
2018
Q2
$6.63M Buy
54,647
+2,941
+6% +$367K 0.15% 85
2018
Q1
$6.63M Sell
51,706
-3,340
-6% -$451K 0.14% 83
2017
Q4
$7.69M Sell
55,046
-3,464
-6% -$483K 0.16% 83
2017
Q3
$7.61M Sell
58,510
-63,732
-52% -$8.45M 0.15% 83
2017
Q2
$16.2M Sell
122,242
-10,145
-8% -$1.29M 0.26% 71
2017
Q1
$16.5M Buy
132,387
+1,035
+0.8% +$124K 0.24% 68
2016
Q4
$15.1M Buy
131,352
+4,725
+4% +$546K 0.23% 71
2016
Q3
$15M Sell
126,627
-6,501
-5% -$789K 0.22% 71
2016
Q2
$16.1M Sell
133,128
-13,125
-9% -$1.49M 0.25% 69
2016
Q1
$15.8M Sell
146,253
-4,841
-3% -$501K 0.23% 72
2015
Q4
$15.5M Buy
151,094
+32,585
+27% +$3.28M 0.23% 71
2015
Q3
$11.1M Buy
+118,509
New +$11.5M 0.16% 79

Other funds holding JNJ

Brandes Investment Partners's JNJ Position: Q1 2026 in Review

Brandes Investment Partners reduced its Johnson & Johnson (JNJ) stake by 33% in Q1 2026, selling an estimated $32.5M and leaving 279,660 shares worth $68.4M. The position accounts for 0.48% of the portfolio, ranked #74.

Brandes Investment Partners first reported a position in JNJ in Q3 2015 and has held it in 43 quarters since. The position peaked at $86.7M in Q4 2025. 4,617 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Brandes Investment Partners held 279,660 shares of Johnson & Johnson worth $68.4M as of Q1 2026.
  • Brandes Investment Partners sold 139,502 Johnson & Johnson shares in Q1 2026, an estimated $32.5M.
  • Johnson & Johnson made up 0.48% of Brandes Investment Partners's portfolio in Q1 2026, its #74 holding.
  • Brandes Investment Partners first reported a position in Johnson & Johnson in Q3 2015 and has held it in 43 quarters since.
  • Brandes Investment Partners's Johnson & Johnson position peaked at $86.7M in Q4 2025.
  • 4,617 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Brandes Investment Partners's 13F filing for Q1 2026, filed 15 May 2026.